The objective of this Phase III double-blind parallel-group controlled study was to examine the superiority of amlodipine 10 mg once daily (the amlodipine 10 mg group) to amlodipine 5 mg once ...

After a 2- to 3-week placebo run-in, subjects were randomized to valsartan 160 mg or amlodipine 5 mg for 2 weeks, and were then force-titrated to valsartan/HCTZ (160/12.5 mg) or amlodipine (10 mg ...

Of these, 10 305 subjects with total cholesterol under 6.5 mmol/L were further randomized to atorvastatin 10 mg daily or placebo.